Table of Contents Table of Contents
Previous Page  622 / 1726 Next Page
Information
Show Menu
Previous Page 622 / 1726 Next Page
Page Background

Survival after relapse in PORTEC-1

PORTEC Post relapse survival - no RT arm

First failure LRMD

0

2

4

6

8

10

0

25

50

75

100

Vaginal

Pelvic

Meta

years

r 2004 - 10:13:55

Logrank P<.001

Vaginal

36 10

Pelvic

10 9

Meta

12 9

N F

PORTEC Post relapse survival

Treatment arm

Cumulative percentage

0

2

4

6

8

10

0

25

50

75

100

RT

no RT

years

29 Apr 2004 - 10:13:55

At risk:

RT 38

12

5

2

1

1

no RT 58

32

25

10

5

1

Logrank P<.001

RT

38 34

no RT 58 28

N F

By treatment arm

By site of relapse

Vaginal brachytherapy?

Creutzberg et al, Gynecol Oncol 2003